Gilead report says coronavirus drug trial shows encouraging early results
A clinical trial of Gilead’s antiviral drug Remdesivir appeared to show promising results in treating Covid-19. The University of Chicago’s phase 3 drug trial found that most of its patients…
(Photo by Morris MacMatzen/Getty Images)
A clinical trial of Gilead's antiviral drug Remdesivir appeared to show promising results in treating Covid-19.
The University of Chicago’s phase 3 drug trial found that most of its patients had “rapid recoveries in fever and respiratory symptoms” and were discharged in less than a week. The University's trial was made up of 125 patients, 113 of them were severely ill.
Gilead plans to enroll 4,000 people in its trials.
This story is developing.
Joe WinnerWriter
Joe Winner spends his days combing through memes and off beat stories to bring you the side of Florida not always seen.
